Auna SA

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Auna reports robust Q2 earnings, eyes growth in Latin America

Auna's Q2 2024 performance reflects strong financial growth and operational improvements across key regions.
The company's strategic strengths lie in patient-centric care, financial discipline, and growth initiatives.
Challenges include meeting ambitious growth targets and managing operational complexities across diverse markets.
Opportunities abound in expanding offerings, leveraging regional growth, and enhancing partnerships for sustained success.

Auna reports robust Q3 earnings, eyes growth in key markets

Auna's Q3 2024 earnings call highlighted strong financial performance, operational efficiency, and growth prospects in key markets, positioning the company for sustained success.
While facing challenges in working capital management and debt leverage, Auna remains focused on addressing these issues to ensure long-term financial stability and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Auna SA engages in the provision of healthcare and medical services. It operates through the following segments: Oncosalud Peru, Healthcare Services in Peru, and Healthcare Services in Colombia. The Oncosalud Peru segment offers prepaid oncology plans and oncology services provided at Oncosalud facilities. The Healthcare Services in Peru segment provides medical services in Peru. The Healthcare Services in Colombia segment manages and operates medical centers in Colombia. The company was founded on November 4, 2008 and is headquartered in Luxembourg.

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the closing of a private placement of USD 57,826,321 aggregate principal amount of its 10.000% Senior Secured Notes due 2029 (the "Additional 2029 Notes"). The proceeds from the Additional 2029 Notes were used to fully redeem the USD 57,826,321 in aggregate principal amount outstanding of its 6.500% Senior Secured.

Auna Announces the Successful Redemption of Its 6.500% Senior Secured Notes Due 2025 With the Proceeds of Private Placement of Notes

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the board.

Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, today announced unaudited financial results for the third quarter ended September 30, 2024 (“third quarter 2024” or “3Q24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q24 Consolidated Highlight.

Auna Announces 3Q24 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2024 financial results. Earnings Release Tuesday, November 19, 2024 Time: After Market Close Conference Call Wednesday, November 20, 2024 Time: 8:00 a.m. ET Quiet Period Monday, November 11 through Tuesday, November 19, 2024 To participate, please dial.

Auna Announces Reporting Dates for Third Quarter 2024 Financial Results

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent “Lorenzo” Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. “We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this new.

Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

Auna (NYSE: AUNA ) just reported results for the second quarter of 2024. Auna reported earnings per share of 3 cents.

AUNA Stock Earnings: Auna Misses EPS, Beats Revenue for Q2 2024

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Colombia and Peru, today announced unaudited financial results for the second quarter ended June 30, 2024 (“second quarter 2024” or “2Q24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 2Q24 Consolidated Highlights C.

Auna Announces 2Q24 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2024 financial results. Earnings Release Wednesday, August 21, 2024 Time: After Market Close Conference Call Wednesday, August 21, 2024 Time: 5:00 p.m. ET Quiet Period Friday, August 2 through Wednesday, August 21, 2024 To participate, please dial +1 8.

Auna Announces Reporting Dates for Second Quarter 2024 Financial Results

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the launch of the first oncology insurance in Mexico, fully integrated through its hospital network in Monterrey, Nuevo Leon. Auna's integrated oncological insurance addresses the unmet needs of families and patients for cancer prevention, detection, and treatment coverage. The product, named after its successful.

Auna Launches the First Integrated Oncology Insurance in Mexico

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), one of the largest and most recognized company in Latin America's healthcare industry with operations in Mexico, Colombia and Peru, today announced unaudited financial results for the three months ended March 31, 2024 (“first quarter 2024” or “1Q24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise.

Auna Announces 1Q24 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2024 financial results. Earnings Release Wednesday, May 22, 2024 Time: After Market Close Conference Call Wednesday, May 22, 2024 Time: 5:00 p.m. ET Quiet Period Wednesday, May 8 through Wednesday, May 22, 2024 To participate, please dial +1 888 596 414.

Auna Announces Reporting Dates for First Quarter 2024 Financial Results

Astera Labs Inc

Black Hawk Acquisition Corp

Boundless Bio Inc

Intelligent Group Ltd

Mobile-Health Network Solutions

Reddit Inc

Four IPOs (Astera Labs, Reddit, Auna & Intelligent Group) priced this past week, joined by one SPAC (Black Hawk Acquisition). Two sizable issuers submitted initial filings - Centuri Holdings and Ibotta.

U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced it has launched its Initial Public Offering (“IPO”) on the New York Stock Exchange and has begun trading under the ticker “AUNA”. The Company raised US$360 million in gross proceeds by issuing 30,000,000 million class A shares (“class A shares”), at a price of US$12.00 per class A share. Suso Zamora, Executive Chairman o.

Auna Raises US$360 Million in Gross Proceeds via NYSE IPO, Marking Its Debut in the International Equity Markets

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna”) a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it has priced its initial public offering of 30,000,000 class A ordinary shares (“class A shares”), at a price of US$12.00 per class A share. Auna intends to use the net proceeds from the offering to repurchase 21.2% interest in Auna Salud S.A.C., as well as for other general corporate purposes, as described in its registration statement on Form.

Auna Announces Pricing of Initial Public Offering of US$360 Million (Gross Proceeds) of Class A Shares

News for Auna SA Stock (AUNA)